Subtopic Deep Dive
HIV Latency and Viral Reservoirs
Research Guide
What is HIV Latency and Viral Reservoirs?
HIV latency refers to the quiescent state of HIV provirus integrated into host genomes in resting CD4+ T cells and other reservoirs, persisting despite antiretroviral therapy and causing viral rebound upon treatment cessation.
Latent reservoirs form early in infection and are maintained by T cell survival and homeostatic proliferation (Chomont et al., 2009, 1696 citations). Cellular microRNAs contribute to latency in resting primary CD4+ T cells (Huang et al., 2007, 752 citations). Single-cell analyses and reactivation strategies target these reservoirs for HIV cure.
Why It Matters
Eradicating latent reservoirs is essential for HIV cure, as they drive viral persistence and rebound after therapy interruption, as shown in the ANRS VISCONTI study where early-treated patients achieved long-term remission (Sáez‐Cirión et al., 2013, 980 citations). Reservoir size correlates with T cell proliferation, informing 'shock and kill' strategies (Chomont et al., 2009). Cytolytic T lymphocytes eliminate reactivated latent cells, advancing functional cure approaches (Shan et al., 2012, 701 citations).
Key Research Challenges
Quantifying reservoir size
Residual HIV replication persists in some patients on combination therapy, complicating accurate measurement of latent reservoirs (Zhang et al., 1999, 823 citations). Techniques must distinguish defective from replication-competent proviruses. Homeostatic T cell proliferation drives reservoir maintenance (Chomont et al., 2009).
Reactivating latent provirus
Latency reversal agents often fail to fully reactivate reservoirs without toxicity. MicroRNAs suppress HIV expression in resting CD4+ T cells (Huang et al., 2007). Immune clearance post-reactivation remains inefficient (Shan et al., 2012).
Achieving reservoir elimination
Post-treatment controllers show remission but persistent low-level reservoirs. Early ART initiation reduces but does not eliminate reservoirs (Sáez‐Cirión et al., 2013). T cell survival sustains reservoirs despite therapy (Chomont et al., 2009).
Essential Papers
CD4+ Count–Guided Interruption of Antiretroviral Treatment
Wafaa El‐Sadr · 2006 · New England Journal of Medicine · 2.2K citations
BACKGROUND Despite declines in morbidity and mortality with the use of combination antiretroviral therapy, its effectiveness is limited by adverse events, problems with adherence, and resistance of...
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont, Mohamed El‐Far, Petronela Ancuța et al. · 2009 · Nature Medicine · 1.7K citations
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Sáez‐Cirión, Charline Bacchus, Laurent Hocqueloux et al. · 2013 · PLoS Pathogens · 980 citations
Combination antiretroviral therapy (cART) reduces HIV-associated morbidities and mortalities but cannot cure the infection. Given the difficulty of eradicating HIV-1, a functional cure for HIV-infe...
HIV-1 Antiretroviral Drug Therapy
Eric J. Arts, Daria J. Hazuda · 2012 · Cold Spring Harbor Perspectives in Medicine · 837 citations
The most significant advance in the medical management of HIV-1 infection has been the treatment of patients with antiviral drugs, which can suppress HIV-1 replication to undetectable levels. The d...
The immune response during acute HIV-1 infection: clues for vaccine development
Andrew J. McMichael, Persephone Borrow, Georgia D. Tomaras et al. · 2009 · Nature reviews. Immunology · 834 citations
Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
Linqi Zhang, Bharat Ramratnam, Klara Tenner‐Racz et al. · 1999 · New England Journal of Medicine · 823 citations
These findings suggest that combination antiretroviral regimens suppress HIV-1 replication in some but not all patients. Given the half-life of latently infected CD4 lymphocytes of about six months...
Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes
Jialing Huang, Fengxiang Wang, Elias G. Argyris et al. · 2007 · Nature Medicine · 752 citations
Reading Guide
Foundational Papers
Start with Chomont et al. 2009 (1696 citations) for mechanisms of reservoir persistence via T cell homeostasis, then Zhang et al. 1999 (823 citations) for residual replication quantification.
Recent Advances
Sáez‐Cirión et al. 2013 (980 citations) on post-treatment controllers; Shan et al. 2012 (701 citations) on T cell elimination of reactivated reservoirs.
Core Methods
Viral outgrowth assays (Zhang 1999); microRNA profiling (Huang 2007); cytolytic T cell stimulation (Shan 2012).
How PapersFlow Helps You Research HIV Latency and Viral Reservoirs
Discover & Search
Research Agent uses searchPapers and citationGraph on 'Chomont et al. 2009' to map 1696-cited works on T cell-driven reservoirs, then exaSearch for single-cell latency studies and findSimilarPapers for recent epigenetic analyses.
Analyze & Verify
Analysis Agent applies readPaperContent to extract reservoir quantification methods from Zhang et al. 1999, verifies claims with CoVe against Chomont et al. 2009, and runs PythonAnalysis for statistical modeling of half-life decay (6 months for latently infected CD4 cells) with GRADE scoring for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in reactivation efficiency across Shan et al. 2012 and Huang et al. 2007, flags contradictions in reservoir persistence models; Writing Agent uses latexEditText, latexSyncCitations for 10 key papers, and latexCompile to generate eradication strategy reviews with exportMermaid for reservoir dynamics diagrams.
Use Cases
"Model HIV reservoir decay rates from patient cohort data"
Research Agent → searchPapers 'reservoir half-life' → Analysis Agent → readPaperContent (Zhang 1999) → runPythonAnalysis (pandas/NumPy fit exponential decay to CD4 half-life data) → matplotlib plot of projected eradication timelines.
"Write review on latency reversal agents with citations"
Research Agent → citationGraph 'Shan 2012' → Synthesis → gap detection in T cell elimination → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (10 papers) → latexCompile → PDF with reservoir reactivation figure.
"Find code for single-cell HIV provirus sequencing"
Research Agent → searchPapers 'single-cell HIV latency' → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → exportCsv of analysis pipelines for epigenetic profiling.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ reservoir papers: searchPapers → citationGraph (Chomont 2009 hub) → structured report on persistence drivers. DeepScan applies 7-step analysis with CoVe checkpoints to verify reactivation claims in Shan et al. 2012. Theorizer generates hypotheses on microRNA-targeted therapies from Huang et al. 2007 literature synthesis.
Frequently Asked Questions
What defines HIV latency?
HIV latency is proviral integration into resting CD4+ T cell genomes, transcriptionally silent despite ART, maintained by T cell survival (Chomont et al., 2009).
What methods study reservoirs?
Quantitative viral outgrowth assays measure replication-competent units; single-cell RNA-seq profiles latency markers (Zhang et al., 1999; Huang et al., 2007).
What are key papers?
Chomont et al. 2009 (1696 citations) on T cell proliferation; Shan et al. 2012 (701 citations) on immune clearance post-reactivation.
What open problems remain?
Full reservoir eradication; scalable reactivation without toxicity; distinguishing defective vs. intact proviruses (Sáez‐Cirión et al., 2013).
Research HIV Research and Treatment with AI
PapersFlow provides specialized AI tools for Immunology and Microbiology researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching HIV Latency and Viral Reservoirs with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Immunology and Microbiology researchers
Part of the HIV Research and Treatment Research Guide